Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;: genes and variants

Explore variant evidence for Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; across 2 analyzed proteins (MFN2, ATP1A1). Linked ClinVar records include 15 pathogenic or likely pathogenic variants, 18 variants of uncertain significance and 11 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-10-10. Automated aggregation, not a clinical review date.

Other source names: charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b

Download variant evidence (CSV)

Genes linked to Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;

Where Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;

VariantPositionProtein partClinical label
ATP1A1 P600A600Mediates interaction with SCN7APathogenic / likely pathogenic (★★)
MFN2 R94W94Dynamin-type GPathogenic / likely pathogenic (★★)
MFN2 R94Q94Dynamin-type GPathogenic / likely pathogenic (★★)
ATP1A1 I592T592CytoplasmicPathogenic / likely pathogenic (★★)
MFN2 R280H280Dynamin-type GPathogenic / likely pathogenic (★★)
MFN2 T362M362Part of a helix bundle domain, formed by helicesPathogenic / likely pathogenic (★★)
MFN2 R707W707Coiled coilPathogenic / likely pathogenic (★★)
ATP1A1 L844P844CytoplasmicPathogenic / likely pathogenic (★★)
MFN2 R104W104Dynamin-type GPathogenic / likely pathogenic (★★)
MFN2 W740S740Part of a helix bundle domain, formed by helicesPathogenic / likely pathogenic (★★)
MFN2 R476G476CytoplasmicPathogenic / likely pathogenic (★★)
ATP1A1 P600R600Mediates interaction with SCN7APathogenic / likely pathogenic (★)
ATP1A1 E334G334TransmembranePathogenic / likely pathogenic
ATP1A1 G549R549CytoplasmicPathogenic / likely pathogenic
MFN2 E52K52Part of a helix bundle domain, formed by helicesPathogenic / likely pathogenic

Which prediction tools work for Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;

Frequently asked questions

Which genes have records linked to Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;?

This view contains 2 analyzed proteins: MFN2, ATP1A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 15 pathogenic or likely pathogenic variants, 18 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 54 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center